I can try. Before answering the question, I have to say that representatives of the Patented Medicine Prices Review Board will appear before the committee on Thursday afternoon. They will surely be able to give you more details.
Generally, the workload deriving from conflicts between pharmaceutical companies, which require a more formal procedure, has been quite high in the past few years. So operating costs have increased accordingly.